Key Developments: Misonix Inc (MSON.O)
2.09USD
9 Feb 2010
$-0.04 (-1.88%)
$2.09
--
$2.09
$2.09
1,100
12,158
$2.94
$0.70
Latest Key Developments
Misonix, Inc. Announces New Distribution Agreement For Brazil
Misonix, Inc. announced that it has entered into a new, three year distribution agreement with Neuro Orthopaedics Surgeries, based near Rio de Janeiro, Brazil, for the distribution of the SonaStar Ultrasonic Surgical Aspirator and the BoneScalpel Ultrasonic Bone Cutter. The agreement provides Neuro Orthopaedics Surgeries with the right to sell exclusively in Brazil and includes minimum purchase requirements.
Misonix, Inc. Announces New Distribution Agreement For Peru
Misonix, Inc. announced that it has entered into a new, three year, exclusive distribution agreement with ROCA, S.A.C., based in Lima, Peru, for the distribution of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutter, and the SonicOne Ultrasonic Wound Debrider. The agreement provides ROCA with the rights to sell in Peru, and includes minimum purchase requirements.
Misonix, Inc. Announces New Distribution Agreement For Argentina
Misonix, Inc. announced that it has entered into a new, three year distribution agreement with Chirugia, S.A., based in Buenos Aires, Argentina, for the distribution of the SonaStar Ultrasonic Surgical Aspirator and the BoneScalpel Ultrasonic Bone Cutter. The agreement provides Chirugia with the rights to sell exclusively in Argentina and includes minimum purchase requirements.
Misonix, Inc. Announces New Distribution Agreement For UAE
Misonix, Inc. announced that it has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutter, and the SonicOne Ultrasonic Wound Debrider. The agreement provides Xenith with the rights to sell exclusively in The United Arab Emirates (UAE) and other select markets and includes minimum purchase requirements.
Misonix, Inc. Announces Sale of Sonora Medical Systems For $8 Million
Misonix, Inc. announced that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
Misonix, Inc. Restructures and Expands Sales Organization In Europe; Two Business Units Have Been Created
Misonix, Inc. announced the restructuring and expansion of its sales organization in Europe. Two business units have been created; one for sales and service of the Sonablate 500 High Intensity Focused Ultrasound (HIFU) System and the other for sales and service of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutting System and the SonicOne Ultrasonic Wound Cleansing and Debridement System. The new Misonix HIFU Technologies business unit, which will be headed by Nick Stevens, will focus on a fee for use business model that will feature a combination of mobile services delivered directly to hospitals and centers of excellence to which qualified patients can be referred. The Company's UKHIFU and Misonix France business units, which were created to support the fee for service business model, will be integrated into Misonix HIFU Technologies and will be overseen by the same management team.
Misonix, Inc. Announces Sale Of Labcaire Business For Up To $5.6 Million
Misonix, Inc. announced the sale of its Labcaire subsidiary to PuriCore International Limited for a total purchase price of up to $5.6 million. Misonix received $3,600,000 at closing and a promissory note in the principal amount of $1,000,000, payable in equal installments of $250,000 on the next four anniversaries of the closing. Misonix will also receive a commission paid on sales for the period commencing on the date of closing and ending on December 31, 2013 of 8% of the pass through Automated Endoscope Reprocessing (AER) and Drying Cabinet products, and 5% of license fees from any chemical licenses marketed by Labcaire directly associated with sales of AER's, specifically for the disinfection of the endoscope. The aggregate commission payable to Misonix is subject to a maximum payment of $1,000,000.
Misonix, Inc. Receives First Award For Forensic Equipment In China
Misonix, Inc. announced receipt of its first award for forensic equipment in China from the Company's distributor CSI Technology/CStrace International. This equipment will be supplied to Chinese Law Enforcement in a major city in China. This award came from a competitive bid which focused on quality and performance. The Company expects to deliver the order in its second fiscal quarter 2010.
Misonix, Inc. Announces Purchase of Patents From ProRhythm, Inc.
Misonix, Inc. announced that it has purchased three patents associated with High Intensity Focused Ultrasound (HIFU) technology from ProRhythm, Inc. The patents relate to HIFU transducer arrays method of fabrication, ultrasonic lenses, and an intrabody HIFU applicator. The purchase also includes prototypes, transducers and equipment.
Misonix, Inc. Announces New HIFU Distribution Agreement For Romania And Bulgaria
Misonix, Inc. announced that it has entered into a definitive, five year distribution agreement with DTL Medical srl, based in Craiova, Romania. Under the terms of the agreement, DTL will market the Sonablate 500 High Intensity Focused Ultrasound (HIFU) System as a mobile, fee for use service to hospitals in Romania and Bulgaria. Misonix and DTL will share the fee for use revenue for the length of the agreement plus any extension periods. Procedure minimums for fee per use revenue are part of the agreement.
UPDATE 3-Deals of the day -- mergers and acquisitions
** Poland sold a 3 percent stake in the country's No. 2 bank Pekao for 1.08 billion zlotys ($379 million) as it collects funds to plug a budget gap, but it failed to sell its entire holding due to a high price. [ID:nL5218688]
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
